Why is the CSL share price sliding lower on Monday?

Investors should be stoked with CSL's share price drop today.

| More on:
woman testing substance in laboratory dish, csl share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a rough start to the week for the S&P/ASX 200 Index (ASX: XJO) and ASX shares. At the time of writing, the ASX 200 has opened 0.14% lower so far this Monday. But let's talk about the CSL Limited (ASX: CSL) share price. 

If you thought the ASX 200's start to the week was disappointing, wait until you see what's going on with CSL shares. The ASX 200 healthcare stock closed last week at a share price of $270.85. But this morning, CSL opened at $269 a share and is currently going for just $266.65 at the time of writing, down a nasty 1.55% for the day so far.

Before any CSL investors get carried away with wondering what's going wrong with their investment today, it's worth pointing out that there's a good reason for CSL's rather steep drop this Monday. This healthcare share has just traded ex-dividend for its upcoming shareholder payment.

CSL share price stutters as company trades ex-dividend

Last month, we analysed CSL's latest earnings report, covering the full 2023 financial year. It was a well-received earnings report at the time, with the healthcare giant revealing that it had managed to grow revenues by a healthy 31% in constant currency terms to US$13.31 billion.

Net profits after tax before amortisation rose by 20% in constant currency to US$2.86 billion, while reported net profits lifted by 10% to US$2.61 billion.

That enabled CSL to boost its final dividend for 2023 by 9.3% to US$1.29 per share, partially franked at 10%. That's the largest dividend CSL has ever paid out. This payment takes the company's full-year dividends to US$2.36 per share, up 6% from last year.

However, as we warned last week, CSL's ex-dividend date for this supersized shareholder payment is today. This means that anyone buying CSL shares from today onwards is not eligible to receive this latest dividend.

That's why we are seeing such a dramatic fall in the CSL share price this Monday relative to the ASX 200. It usually happens when an ASX share trades ex-dividend, and reflects this inherent loss of value for new investors going forward.

So existing CSL investors have nothing to complain about with their company seeing a share price drop today. It's the best reason to see a company have a red day on the markets.

CSL shareholders can now look forward to receiving their latest dividend next month on 4 October.

Right now, CSL shares have a dividend yield of 1.15%. The CSL share price remains down by 5.5% in 2023 to date, as well as by 10.1% over the past 12 months, as you can see below:

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientist with headache, stress and fatigue with woman, overworked with overtime for science breakthrough. Medical research, scientific innovation and senior female, burnout and migraine in lab.
Healthcare Shares

Why is the Mesoblast share price in a trading halt?

Is Mesoblast raising funds again? Let's find out.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

The CSL share price return tripled the ASX 200 in November

November saw a very healthy return for CSL shares.

Read more »

A male doctor wearing a white doctor's coat shrugs and holds his hands up to indicate the unimpressive CSL share price as a result of OOVID-19
Share Market News

Here's why you might have just bought Healius shares

Two of the most popular super funds just loaded up on this healthcare stock.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Here's why this ASX 200 healthcare stock is roaring 13% higher on Wednesday

This healthcare company is outperforming every other stock within the ASX 200 today.

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop

Could CSL stock be a millionaire-maker at $261

Does the exceptional biotech company still harness the power to make an investment today worth a million in the future?

Read more »

Two happy scientists analysing test results in a lab
Healthcare Shares

Why are Mesoblast shares charging 5% higher today?

This beaten down biotech is having a strong session. But why?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Healius share price rallies amid corporate reset

An outgoing chair and a revitalised balance sheet. Healius is undergoing a makeover.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Imugene share price jumps 32% on FDA news

Here's why this biotech is having a strong start to the session.

Read more »